Lymphocyte activation gene-3 (LAG-3, CD223) in plasmacytoid dendritic cells (pDCs): a molecular target for the restoration of active antitumor immunity.
第一作者:
Chiara,Castelli
第一单位:
Unit of Immunotherapy of Human Tumors; Dept. of Experimental Oncology and Molecular Medicine; Fondazione IRCCS Istituto Nazionale dei Tumori ; Milano, Italy.
作者:
关键词
ADCC, antibody-dependent cell cytotoxicityAPCs, antigen-presenting cellsDDCs, dermal dendritic cellsIMP-321LAG-3, lymphocyte activation gene-3LNs, lymph nodesMDSCs, myeloid-derived suppressor cellsPD-1, programmed cell death 1TLRs, toll-like receptorsTregs, regulatory T cells.lymphocyte activation gene-3 (LAG-3)mAbs, monoclonal antibodiesmelanomapDCs, plasmacytoid dendritic cellsplasmacytoid dendritic cells (pDCs)psoriasis
DOI
10.4161/21624011.2014.967146
PMID
25941596
发布时间
2021-02-18
- 浏览9
Oncoimmunology
e967146页
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文


换一批



